NewswireToday - /newswire/ -
King of Prussia, PA, United States, 2017/11/23 - Leader in financial technology for clinical trials celebrates increasing demand for rapid, secure and transparent payment processes - Deloitte.com / Greenphire.com.
Greenphire, the global leader in financial technology for clinical trials, announced today that it was named to the Deloitte’s Technology Fast 500™ for the fourth consecutive year. This recognition ranks the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. Greenphire is listed 386 this year, exhibiting a 208.7 percent growth over a three-year period.
“Greenphire is setting the industry standard for rapid, secure and reliable clinical trial payment execution,” said Jim Murphy, CEO of Greenphire. “Our continued year-over-year growth reflects the industry’s focus on transforming payment processes to support clinical research. We are honored to once again be named among the most elite, fastest-growing companies in North America.”
Greenphire transforms payment processing, supporting monthly site payments globally with eClinicalGPS and instant, secure participant stipend and reimbursements on a reloadable debit card, with ClinCard. With more than 500 clients, including 9 of the top 10 pharmaceutical companies, Greenphire has facilitated more than five million participant reimbursements and 700,000 automated investigator payments.
This continued recognition for the fourth consecutive year is a testament to the team’s ability to establish and maintain trusting relationships with its client partners and deliver the most sophisticated technology to scale with the dynamic needs of clinical research.
Greenphire (greenphire.com) is the leader in global clinical trial payment automation. Greenphire’s best-in-class software optimize clinical trial performance by streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials.